Kumagai Koichiro | Heart Rhythm Center Fukuoka Sanno Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Do Valsartan and Losartan Have the Same Effects in the Treatment of Coronary Artery Disease?
Optimal Treatment Strategy for Patients With Paroxysmal Atrial Fibrillation : J-RHYTHM Study(Arrhythmia/Electrophysiology)
Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropiridine Calcium Antagonist for the Treatment of Paroxysmal Atrial Fibrillation in Patients With Hypertension : The J-RHYTHM II Study Design for the Investigation of Upstream Therapy for
Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan : The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study Design
Rate Control and Quality of Life in Patients With Permanent Atrial Fibrillation : The Quality Of Life and Atrial Fibrillation (QOLAF) Study
Pharmacological Conversion of Persistent Atrial Fibrillation Into Sinus Rhythm With Oral Pilsicainide : Pilsicainide Suppression Trial for Persistent Atrial Fibrillation II(Clinical Investigation)
Long-Term Effects of Box Isolation on Sympathovagal Balance in Atrial Fibrillation
Dose-Response Effects of Bepridil in Patients With Persistent Atrial Fibrillation Monitored With Transtelephonic Electrocardiograms : A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (J-BAF Study)
Associations Between Augmentation Index and Severity of Atheroma or Aortic Stiffness of the Descending Thoracic Aorta by Transesophageal Echocardiography
Reperfusion-induced Aarrhythmias are Suppressed by Reconstituted High-density Lipoprotein in Rats(Arrhythmia, Basic 4 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Novel Electrophysiologic Parameter of Dispersion of Atrial Repolarization : Comparison of Different Atrial Pacing Methods
Efficacy and Safety of Catheter Ablation for Persistent or Permanent Atrial Fibrillation
Histochemical Characteristics of Soleus Muscle in Angiotensin-Converting Enzyme Gene Knockout Mice
Characteristics of Brugada Syndrome with Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
A Comparative Crossover Study of the Effects of Fluvastatin and Pravastatin (FP-COS) on Circulating Autoantibodies to Oxidized LDL in Patients with Hypercholesterolemia
OE-283 ApoA-I/Phosphatidylcholine Discs Reduce Charge-Modified LDL as Characterized by Capillary Isotachophoresis(Lipid disorders-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Ratio of LDL- to HDL-Associated Platelet-Activating Factor Acetylhydrolase may be a Marker of Inflammation in Patients With Paroxysmal Atrial Fibrillation
OE-111 Negative-charged LDL and LDL-associated Platelet-activating Factor Acetylhydrolase may be Therapeutic Target for Preventing Paroxysmal Atrial Fibrillation(Arrhythmia, therapy-2 (A) OE19,Oral Presentation (English),The 70th Anniversary Annual Scient
Angiotensin II Type 1 Receptor Blockers Do Not Promote Coronary Collateral Circulation in Patients with Coronary Artery Disease
Warfarin may have an Anti-inflammatory Effect with the Reduction of Plasma RANTES(Arrhythmia, Pharmacological Therapy 5 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Efficacy of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
Severity of Coronary Atherosclerosis in Relation to Hypertension and Dyslipidemia
RELATION BETWEEN THE RATIO OF CONDUCTION DELAY TO REFRACTORY PERIOD AND SUSCEPTIBILITY TO ATRIAL FIBTILLATION
ARB as an Upstream Therapy for Preventing Atrial Fibrillation(Atrial Fibrillation : Innovation of the Therapeutic Strategies, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version
Effect of Different Atrial Pacing on Pulmonary Venous Pressure(Arrhythmia, Diagnosis/Pathophysiology/EPS 7 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Effectiveness of Pulmonary Vein Isolation on Atrial Arrhythmogenicity(Arrhythmia, Non-pharmacological Therapy 3 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Effects of Pilsicainide on the Pulmonary Veins and Pulmonary Vein-Left Atrial Junction in Patients With Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 1 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Comparison of a Pilsicainide and Nifekalant Channel Blocker on Electrophysiological Properties of the Pulmonary Veins in Patients With Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 5 (A), The 69th Annual Scientific Meeting of the Japanese Circul
Relation Between Pulmonary Vein Morphology and Electrophysiological Properties(Arrhythmia, Diagnosis/Pathophysiology/EPS 4 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Characteristics of Atrial Fibrillation Initiated by Non-Pulmonary Vein Foci : Comparison With Pulmonary Vein Foci(Arrhythmia, Non-pharmacological Therapy 5 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Electrophysiological Factors to Form Reentrant Circuits in Pulmonary Veins(Arrhythmia, Diagnosis/Pathophysiology/EPS 10 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Relation Between Stretch of Pulmonary Vein and Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 10 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Conduction Recovery After Pulmonary Vein Isolation for Atrial Fibrillation
Genetic Analysis of Brugada Syndrome in Western Japan : Two Novel Mutations
PJ-014 Clinical Characteristics of Brugada Syndrome with Atrial Arrhythmias(Arrhythmia, Diagnosis/Pathophysiology/EPS 5 (A) : PJ3)(Poster Session (Japanese))
OJ-285 Pulmonary Vein Isolation Using a Basket Catheter for Atrial Fibrillation : Comparison with a Circular Mapping Catheter(Arrhythmia, Non-Pharmacological Therapy 10 (A) : OJ34)(Oral Presentation (Japanese))
OJ-284 Hybrid Therapy With Pilsicainide and Pulmonary Vein Isolation For Atrial Fibrillation(Arrhythmia, Non-Pharmacological Therapy 10 (A) : OJ34)(Oral Presentation (Japanese))
OJ-261 Pulmonary Vein Isolation Improves Atrial Arrhythmogenic Substrates in Patients with Atrial Fibrillation(ECG/Body Surface Potential Mapping/Holter 3 (A) : OJ30)(Oral Presentation (Japanese))
Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
Antithrombotic Therapy in Atrial Fibrillation : Evaluation and Positioning of New Oral Anticoagulant Agents
OJ-094 Effects of Pilsicainide on Electrophysiological Properties of the Pulmonary Veins in Patients with Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 7 (A) : OJ12)(Oral Presentation (Japanese))
OE-230 Electrophysiological Properties of Pulmonary Veins and Pulmonary Vein-Left Atrial Junction Assessed Using a Multielectrode Basket Catheter(Arrhythmia, Diagnosis/Pathophysiology/EPS 10 (A) : OE28)(Oral Presentation (English))
Catheter Ablation of Atrial Fibrillation : State of the Art
Box Isolation for Atrial Fibrillation
Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
A New Attempt to Scrutinize the Culprit CFAE Using Antiarrhythmic Drugs Aiming at Optimal Defragmentation
Guidelines for Clinical Cardiac Electrophysiologic Studies (JCS 2011) : Digest Version

もっと見る

スポンサーリンク